BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 22400184)

  • 1. [Irritable bowel syndrome--irritable bowel or irritable mind?].
    Marlicz W; Zawada I; Starzyńska T
    Pol Merkur Lekarski; 2012 Jan; 32(187):64-9. PubMed ID: 22400184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
    Malagelada JR
    Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
    Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome.
    Malone MA
    Prim Care; 2011 Sep; 38(3):433-47; viii. PubMed ID: 21872090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders.
    Alpers DH
    J Psychosom Res; 2008 Jun; 64(6):567-72. PubMed ID: 18501256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role.
    Bolino CM; Bercik P
    Infect Dis Clin North Am; 2010 Dec; 24(4):961-75, ix. PubMed ID: 20937460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM; Shiff SJ; Quigley EM
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome: a population based study.
    Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
    Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disease concept and definition of irritable bowel syndrome].
    Hongo M; Sato Y
    Nihon Rinsho; 2006 Aug; 64(8):1415-9. PubMed ID: 16898604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower gastrointestinal disorders in patients with irritable bowel syndrome.
    Jurcić D; Bilić A; Schwarz D; Luetic K; Marusić M; Vcev A; Gabrić M; Spoljarić L
    Coll Antropol; 2008 Sep; 32(3):755-9. PubMed ID: 18982748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.